Citations 1
Dihydropyrimidine dehydrogenase gene (DPYD) polymorphism among pts with 5-FU/capecitabine (CAP)-related adverse events (AEs): Experience of 2 decades.
Siddiqui, Nauman , Purvey, Sneha , Hamal, Ruchi , Diasio, Robert B. , Saif, Wasif M., Zhang, Lulu
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 2576-2576
